Table 1.
Treatments | Pre-grafting experiment |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Groups | RT-PCR reaction |
Percentage of infection |
Disease severity% |
||||||||||||
R1 |
R2 |
R3 |
Virus infectivity (I) |
||||||||||||
r1 | r2 | r3 | r1 | r2 | r3 | r1 | r2 | r3 | R1 | R2 | R3 | (%) | DG | DS% | |
(Control healthy) | − | − | − | − | − | − | − | − | − | 0/3 | 0/3 | 0/3 | 0.00 | 0 | 00.00 |
(Control infected) | + | + | + | + | + | + | + | + | + | 3/3 | 3/3 | 3/3 | 100 | 4 | 100 |
FLMaV-1 and Thuja extract | + | + | + | + | + | + | + | + | + | 3/3 | 3/3 | 3/3 | 100 | 4 | 100 |
FLMaV-1 and ginger extract | − | − | − | − | − | − | + | − | − | 0/3 | 0/3 | 1/3 | 11.11 | 1 | 2.78 |
FLMaV-1 and Harmal extract | + | + | + | + | + | + | + | + | + | 3/3 | 2/3 | 3/3 | 100 | 4 | 88.89 |
FLMaV-1 and turmeric extract | − | + | + | − | − | + | − | − | − | 2/3 | 1/3 | 0/3 | 33.33 | 2 | 16.67 |
Post-grafting experiment | |||||||||||||||
(Control healthy) | − | − | − | − | − | − | − | − | − | 0/3 | 0/3 | 0/3 | 0.00 | 0 | 00.00 |
(Control infected) | + | + | + | + | + | + | + | + | + | 3/3 | 3/3 | 3/3 | 100 | 4 | 100 |
FLMaV-1 and Thuja extract | − | − | − | − | − | − | − | − | + | 0/3 | 0/3 | 1/3 | 11.11 | 1 | 2.78 |
FLMaV-1 and ginger extract | + | + | + | + | + | + | + | + | + | 3/3 | 3/3 | 3/3 | 100 | 4 | 100 |
FLMaV-1 and Harmal extract | − | − | − | − | + | − | − | − | + | 0/3 | 1/3 | 1/3 | 22.22 | 2 | 11.11 |
FLMaV-1 and turmeric extract | + | + | + | + | + | + | + | + | + | 3/3 | 3/3 | 3/3 | 100 | 4 | 100 |
(DG) = Disease grade. (DS%) = Disease severity percentage. (−) = Positive reaction with RT-PCR. (+) = Negative reaction with RT-PCR.